| pubmed-article:20691641 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20691641 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20691641 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:20691641 | lifeskim:mentions | umls-concept:C0085272 | lld:lifeskim |
| pubmed-article:20691641 | lifeskim:mentions | umls-concept:C1839259 | lld:lifeskim |
| pubmed-article:20691641 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:20691641 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:20691641 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:20691641 | pubmed:dateCreated | 2010-8-20 | lld:pubmed |
| pubmed-article:20691641 | pubmed:abstractText | Spinal and bulbar muscular atrophy is a hereditary motor neuron disease caused by the expansion of a polyglutamine tract in the androgen receptor. At present there are no treatments for spinal and bulbar muscular atrophy, although leuprorelin suppressed the accumulation of pathogenic androgen receptors in a phase 2 trial. We aimed to assess the efficacy and safety of leuprorelin for spinal and bulbar muscular atrophy. | lld:pubmed |
| pubmed-article:20691641 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20691641 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20691641 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20691641 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20691641 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20691641 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20691641 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20691641 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:20691641 | pubmed:issn | 1474-4465 | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:MiyajimaHiroa... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:IshikawaKinya... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:MizusawaHideh... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:TsujinoAkiraA | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:SuzukiKeisuke... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:SobueGenG | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:UchinoMakotoM | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:ItoShoichiS | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:TanakaFumiaki... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:NakanoImaharu... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:WatanabeYasuh... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:YamashitaTaro... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:KatsunoMasahi... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:HasegawaKazuk... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:TsujiShojiS | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:NakashimaKenj... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:YabeIchiroI | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:ShimohataTaka... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:TakeuchiYuY | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:SasakiHidenao... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:FujimotoYasus... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:MoritaMitsuya... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:KanaiKazuakiK | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:AokiMasashiM | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:NishizawaMasa... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:KandaFumioF | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:YamamotoTomot... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:BannoHaruhiko... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:KawashimaMoto... | lld:pubmed |
| pubmed-article:20691641 | pubmed:author | pubmed-author:Japan SBMA... | lld:pubmed |
| pubmed-article:20691641 | pubmed:copyrightInfo | Copyright 2010 Elsevier Ltd. All rights reserved. | lld:pubmed |
| pubmed-article:20691641 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20691641 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:20691641 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20691641 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20691641 | pubmed:pagination | 875-84 | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:meshHeading | pubmed-meshheading:20691641... | lld:pubmed |
| pubmed-article:20691641 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20691641 | pubmed:articleTitle | Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. | lld:pubmed |
| pubmed-article:20691641 | pubmed:affiliation | Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan. | lld:pubmed |
| pubmed-article:20691641 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20691641 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:20691641 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20691641 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20691641 | lld:pubmed |
